title: Evidence that the effect of physical exercise on NK cell activity is mediated by epinephrine.
abstract: The present study was designed to test the hypothesis that the changes in natural killer (NK) cell activity in response to physical exercise were mediated by increased epinephrine concentrations. Eight healthy volunteers 1) exercised on a bicycle ergometer (60 min, 75% of maximal O2 uptake) and 2) on a later day were given epinephrine as an intravenous infusion to obtain plasma epinephrine concentrations comparable with those seen during exercise. Blood samples were collected in the basal state, during the last minutes of exercise or epinephrine infusion, and 2 h later. The NK cell activity (lysis/fixed number of mononuclear cells) increased during exercise and epinephrine infusion and dropped below basal levels 2 h afterward. The increased NK cell activity during exercise and the epinephrine infusion resulted from an increased concentration of NK (CD16+) cells in the peripheral blood. On the other hand, the decreased NK cell activity demonstrated 2 h after exercise and epinephrine infusion did not simply reflect preferential removal of NK cells from the blood, because the proportion of CD16+ cells was normalized. On the basis of the finding that indomethacin abolished the suppressed NK cell activity in vitro and the demonstration of a twofold increase in the proportion of monocytes (CD14+ cells) 2 h after exercise and epinephrine infusion, we suggest that, after stress, prostaglandins released by monocytes are responsible for downregulation of NK cell function. Our findings support the hypothesis that increased plasma epinephrine during physical stress causes a redistribution of mononuclear subpopulations that results in altered function of NK cells.
authors.affiliation: Department of Infectious Diseases, Rigshospitalet, University Hospital, Copenhagen, Denmark.
authors.forename: M
authors.initials: M
authors.lastname: Kappel
authors.forename: N
authors.initials: N
authors.lastname: Tvede
authors.forename: H
authors.initials: H
authors.lastname: Galbo
authors.forename: P M
authors.initials: PM
authors.lastname: Haahr
authors.forename: M
authors.initials: M
authors.lastname: Kjaer
authors.forename: M
authors.initials: M
authors.lastname: Linstow
authors.forename: K
authors.initials: K
authors.lastname: Klarlund
authors.forename: B K
authors.initials: BK
authors.lastname: Pedersen
mesh_terms: D000328:Adult; D004837:Epinephrine / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D015444:Exercise / Q000502:physiology*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007262:Infusions, Intravenous; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects; D008297:Male
chemical_list: D007213:Indomethacin; D004837:Epinephrine